Fig. 4
From: MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
The effect of MYO18B on PI3K/AKT pathway. a Western blot assays were used to measure the expression of PI3K, p-PI3K, AKT, P-AKT, mTOR, p-mTOR and p-P70S6K proteins in the transfected HepG2 cells. b Quantification of PI3K, p-PI3K, AKT, P-AKT, mTOR, p-mTOR and p-P70S6K proteins was performed and normalized to the GAPDH a loading control. *P < 0.05 versus si-con group